Hussman Strategic Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-156,000
| Closed | -$674K | – | 299 |
|
|
2023
Q3 | $674K | Hold |
156,000
| – | – | 0.13% | 229 |
|
|
2023
Q2 | $1.03M | Hold |
156,000
| – | – | 0.19% | 213 |
|
|
2023
Q1 | $1.06M | Hold |
156,000
| – | – | 0.17% | 212 |
|
|
2022
Q4 | $1.15M | Hold |
156,000
| – | – | 0.19% | 188 |
|
|
2022
Q3 | $1.54M | Hold |
156,000
| – | – | 0.27% | 156 |
|
|
2022
Q2 | $1.7M | Hold |
156,000
| – | – | 0.29% | 128 |
|
|
2022
Q1 | $1.76M | Hold |
156,000
| – | – | 0.34% | 115 |
|
|
2021
Q4 | $2.45M | Buy |
156,000
+32,000
| +26% | +$502K | 0.54% | 60 |
|
|
2021
Q3 | $2.13M | Buy |
124,000
+31,000
| +33% | +$531K | 0.47% | 84 |
|
|
2021
Q2 | $2M | Buy |
93,000
+21,000
| +29% | +$452K | 0.41% | 86 |
|
|
2021
Q1 | $1.08M | Buy |
72,000
+21,000
| +41% | +$315K | 0.22% | 177 |
|
|
2020
Q4 | $670K | Buy |
51,000
+16,000
| +46% | +$210K | 0.18% | 201 |
|
|
2020
Q3 | $338K | Buy |
+35,000
| New | +$338K | 0.09% | 236 |
|